{
    "clinical_study": {
        "@rank": "77298", 
        "arm_group": [
            {
                "arm_group_label": "Study group", 
                "description": "ECMO Patients survived"
            }, 
            {
                "arm_group_label": "Control", 
                "description": "ECMO Patient died"
            }
        ], 
        "brief_summary": {
            "textblock": "The study is to show the prognostic factor of HRV parameter and cardiac fibrosis markers in\n      critical illness patients"
        }, 
        "brief_title": "The Analysis of Heart Rate Variability With 24hrs Holter ECG and Serum Cardiac Fibrosis Markers in Critical Illness Patients Who Are With Cardiogenic Shock, With ECMO or IABP Support, or With APACH II Score >25)", 
        "completion_date": {
            "#text": "December 2009", 
            "@type": "Actual"
        }, 
        "condition": [
            "Cardiogenic Shock,", 
            "With ECMO or IABP Support,", 
            "With APACH II Score >25)"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Critical Illness", 
                "Fibrosis", 
                "Shock", 
                "Shock, Cardiogenic"
            ]
        }, 
        "detailed_description": {
            "textblock": "The analysis of Heart Rate Variability with 24hrs Holter ECG and serum cardiac fibrosis\n      markers in critical illness patients who are with cardiogenic shock, with ECMO or IABP\n      support, or with APACH II score >25)"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  critical illness patients who are with cardiogenic shock, with ECMO or IABP support,\n             or with APACH II score >25)\n\n        Exclusion Criteria:\n\n          -  pacemaker rhythm, not sign the permit"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Probability Sample", 
            "study_pop": {
                "textblock": "adult age>18 years old"
            }
        }, 
        "enrollment": {
            "#text": "106", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "October 29, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01993745", 
            "org_study_id": "200804046R"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "ECMO", 
            "APACH II score"
        ], 
        "lastchanged_date": "November 20, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Taipei", 
                    "country": "Taiwan"
                }, 
                "name": "National Taiwan University Hospital"
            }
        }, 
        "location_countries": {
            "country": "Taiwan"
        }, 
        "number_of_groups": "2", 
        "official_title": "The Analysis of Heart Rate Variability With 24hrs Holter ECG and Serum Cardiac Fibrosis Markers in Critical Illness Patients Who Are With Cardiogenic Shock, With ECMO or IABP Support, or With APACH II Score >25)", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Taiwan: Department of Health", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "May 2009", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "Outcome measurement:\nThe measure is a composite outcome measure consisting of multiple measures (results to be reported as a single value for each Arm/Group), no changes are required\nList the primary condition or disease being studied Shock needing ECMO support", 
            "measure": "Heart Rate Variability and serum cardiac fibrosis markers in critical illness patients", 
            "safety_issue": "No", 
            "time_frame": "2-4weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01993745"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "National Taiwan University Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "National Taiwan University Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "May 2008", 
        "study_design": "Observational Model: Case Control, Time Perspective: Cross-Sectional", 
        "study_type": "Observational", 
        "verification_date": "November 2013"
    }
}